Jin-guo, Z., Dong-sheng, G., Na, Y. et al. Effect of Astragalus Injection on left ventricular remodeling in aged patients with acute early-stage myocardial infarction., Chin. J. Integr. Med. 9, 104–107 (2003). https://doi.org/10.1007/BF02838559
Zhang Jin-guo, Gao Dong-sheng, Yang Na, et al. Effect of Astragalus Injection on left ventricular remodeling in aged patients with acute early-stage myocardial infarction[J]. Chinese Journal of Integrative Medicine, 2003,9(2):104-107.
Jin-guo, Z., Dong-sheng, G., Na, Y. et al. Effect of Astragalus Injection on left ventricular remodeling in aged patients with acute early-stage myocardial infarction., Chin. J. Integr. Med. 9, 104–107 (2003). https://doi.org/10.1007/BF02838559DOI:
Zhang Jin-guo, Gao Dong-sheng, Yang Na, et al. Effect of Astragalus Injection on left ventricular remodeling in aged patients with acute early-stage myocardial infarction[J]. Chinese Journal of Integrative Medicine, 2003,9(2):104-107. DOI: 10.1007/BF02838559.
Effect of Astragalus Injection on left ventricular remodeling in aged patients with acute early-stage myocardial infarction
摘要
Objective: To observe the effect of Astragalus Injection (AI) on left ventricular remodeling in aged patients with acute myocardial infarction (AMI).Methods: Patients with AMI were randomly divided into the AI group (46 cases) treated with AI and the control group (46 cases) treated conventionally. Left ventricular end-diastolic volume index (LVEDVI)
left ventricular end-systolic volume index (LVESVI)
anterior endocardial segmental length (ASL) and posterior endocardial segmental length (PSL) were all assessed by echocardiogram after 1 week and 4 weeks treatment. The cardiac systolic and diastolic functions were detected by nuclide gating cardiac blood pool imaging at the 4th week.Results: After four weeks’ treatment
no obvious change of LVEDVI
LVESVI and ASL in the AI group was found
but these indexes increased significantly in the control group
with significant difference shown between the two groups (P<0.05). As compared with the control group
the left ventricular ejection fraction (LVEF)
left ventricular peak ejecting rate (LVPER) and left ventricular peak filling rate (LVPFR) were heightened
the time for peak filling rate (LVTPFR) in the left ventricle was shortened in the AI group.Conclusion: AI is one of the effective drugs in reversing left ventricular remodeling in aged patients with AMI.
Abstract
Objective: To observe the effect of Astragalus Injection (AI) on left ventricular remodeling in aged patients with acute myocardial infarction (AMI).Methods: Patients with AMI were randomly divided into the AI group (46 cases) treated with AI and the control group (46 cases) treated conventionally. Left ventricular end-diastolic volume index (LVEDVI)
left ventricular end-systolic volume index (LVESVI)
anterior endocardial segmental length (ASL) and posterior endocardial segmental length (PSL) were all assessed by echocardiogram after 1 week and 4 weeks treatment. The cardiac systolic and diastolic functions were detected by nuclide gating cardiac blood pool imaging at the 4th week.Results: After four weeks’ treatment
no obvious change of LVEDVI
LVESVI and ASL in the AI group was found
but these indexes increased significantly in the control group
with significant difference shown between the two groups (P<0.05). As compared with the control group
the left ventricular ejection fraction (LVEF)
left ventricular peak ejecting rate (LVPER) and left ventricular peak filling rate (LVPFR) were heightened
the time for peak filling rate (LVTPFR) in the left ventricle was shortened in the AI group.Conclusion: AI is one of the effective drugs in reversing left ventricular remodeling in aged patients with AMI.
Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59(3): 607–609s.
ZENG Y, ZHU WL, NI C, et al. Effect of thrombolytic therapy in improving left ventricular function in patients with acute myocardial infarction. Chin J Cardiol 1997; 25(3): 192–194.
Editorial Board of Chinese Journal of Cardiology. Reference scheme of thrombolytic therapy conducted in acute myocardial infarction patients. Chin J Cardiol 1996; 24 (5): 328–340.
LIU JG, XU FM, DU WM, et al. Protective effect of Astragalus Injection on anesthetic dog with acute myocardial infarction. Chinese Traditional Patent Medicine 2001; 23(5): 351–353.
LUO HM, DAI RH, LI Y, et al. Nuclear cardiologic study on effective ingredients of Astragalus membraraceus in treating congestive heart failure. Chin J Integr Tradi &. West Med (Chin) 1995; 15(12): 707–709.
CHENG GR, YI SZ. Experimental study on rat’s myocardium protective effect pretreated with Astragalus membraraceus. Chin J Hypertension 2001; 9(4): 316–318.
WANG YS, DENG WL, XUE CS, edit. Pharmacology and Application of Chinese Materia Medica. Second edition. Beijing: People’s Publishing House of Health, 1998: 988–990.
REN P, CHENG ZH, MA YT, etal. Short-term effect of Astragalus Injection on hemodynamics in patients with congestive heart failure. Chin J Integr Tradi & West Med (Chin) 1998; 18(8): 460.
CHEN JC, LI SY, MIAO LJ, et al. Protective effect of Astragalus membraraceus on ultrastructure of in vitro cultured myocardial cells with ischemic, hypoxic, glucose deficit injury. New J TCM 1990; 22(3): 52–53.
HONG Y, XU SZ, ZENG DY, et al. Study of the inhibitory effect of Astragalus Injection on experimental cardiac hypertrophy in rats. Chin Tradi Patient Med 2002; 24(7): 525–529.